<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title> &#187; lymphoma</title>
	<atom:link href="http://pharmaexecnews.com/tag/lymphoma/feed/" rel="self" type="application/rss+xml" />
	<link>http://pharmaexecnews.com</link>
	<description></description>
	<lastBuildDate>Fri, 29 Apr 2011 14:00:12 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.4</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Drug Counterfeiting &#8211; a $200 Billion Business</title>
		<link>http://pharmaexecnews.com/biotechnology/drug-counterfeiting-200-billion-business/</link>
		<comments>http://pharmaexecnews.com/biotechnology/drug-counterfeiting-200-billion-business/#comments</comments>
		<pubDate>Fri, 27 Aug 2010 08:00:20 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Cardiovascular]]></category>
		<category><![CDATA[Central Nervous System]]></category>
		<category><![CDATA[Drug Delivery]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Financial]]></category>
		<category><![CDATA[General News]]></category>
		<category><![CDATA[Generics]]></category>
		<category><![CDATA[Government Policy]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[Industry News Alerts]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[International News]]></category>
		<category><![CDATA[Market News]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[Medical]]></category>
		<category><![CDATA[Medical Patents]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[Regulatory]]></category>
		<category><![CDATA[Women's Health]]></category>
		<category><![CDATA[bioengineering]]></category>
		<category><![CDATA[Bioinformatics Market Potential]]></category>
		<category><![CDATA[biomolecules]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[cancer therapies]]></category>
		<category><![CDATA[generic drugs]]></category>
		<category><![CDATA[lymphoma]]></category>
		<category><![CDATA[molecular biology]]></category>
		<category><![CDATA[Nanotechnology - Revolutionizing R&D to Develop Smarter Therapeutics and Diagnostics]]></category>
		<category><![CDATA[pharmaceutical companies]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[Strategic Alliances in World Pharma and Biotech Markets]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>
		<category><![CDATA[Understanding the Global Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=10638</guid>
		<description><![CDATA[Drug counterfeiting has become a $200-billion business annually, according to the World Customs Organization. By some calculations, the counterfeiting trade has become more lucrative than the narcotics business. It&#8217;s a global problem. The World Health Organization estimates that counterfeit drugs make up ten percent of the drug market worldwide. And experts say that solving it&#8211;or [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/drug-counterfeiting-200-billion-business/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Fastest Growing Therapeutic Classes (by Sales)</title>
		<link>http://pharmaexecnews.com/biotechnology/fastest-growing-therapeutic-classes-sales/</link>
		<comments>http://pharmaexecnews.com/biotechnology/fastest-growing-therapeutic-classes-sales/#comments</comments>
		<pubDate>Tue, 27 Jul 2010 08:00:34 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Analgesics]]></category>
		<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Cardiovascular]]></category>
		<category><![CDATA[Central Nervous System]]></category>
		<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[Companies]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Drug Delivery]]></category>
		<category><![CDATA[Drug Discovery]]></category>
		<category><![CDATA[Drug Trials]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Financial]]></category>
		<category><![CDATA[General News]]></category>
		<category><![CDATA[Generics]]></category>
		<category><![CDATA[Government Policy]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Immune Disorders]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[Industry News Alerts]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[International News]]></category>
		<category><![CDATA[Market News]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[Medical]]></category>
		<category><![CDATA[Medical Patents]]></category>
		<category><![CDATA[Medical Research]]></category>
		<category><![CDATA[New Drugs]]></category>
		<category><![CDATA[Oncology]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[Regulatory]]></category>
		<category><![CDATA[Research Reports]]></category>
		<category><![CDATA[Respiratory]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[Vaccines]]></category>
		<category><![CDATA[Virus]]></category>
		<category><![CDATA[adenoviruses]]></category>
		<category><![CDATA[Bioinformatics Market Potential]]></category>
		<category><![CDATA[biomolecules]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[Breast cancer]]></category>
		<category><![CDATA[c reactive protein]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[cancer therapies]]></category>
		<category><![CDATA[depression]]></category>
		<category><![CDATA[generic drugs]]></category>
		<category><![CDATA[lymph]]></category>
		<category><![CDATA[lymphoma]]></category>
		<category><![CDATA[micro technology]]></category>
		<category><![CDATA[molecular biology]]></category>
		<category><![CDATA[nanobiotechnology]]></category>
		<category><![CDATA[Nanotechnology - Revolutionizing R&D to Develop Smarter Therapeutics and Diagnostics]]></category>
		<category><![CDATA[pharmaceutical companies]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[Pharmacogenomics]]></category>
		<category><![CDATA[Prostate Cancer]]></category>
		<category><![CDATA[Proteomics]]></category>
		<category><![CDATA[Strategic Alliances in World Pharma and Biotech Markets]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>
		<category><![CDATA[Understanding the Global Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=10540</guid>
		<description><![CDATA[Oncologics, lipid regulators, respiratory agents, antidiabetics and anti-ulcerants are the five largest drug classes by sales. But annual sales are only half the story. Which drug classes are booming, and which have plateaued&#8211;or even dropped? IMS Health has released top-line industry data revealing the 15 largest drug classes, and we&#8217;ve crunched the numbers to take a closer [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/fastest-growing-therapeutic-classes-sales/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Merck KGaA&#8217;s Pancreatic Cancer Vaccine Ready for Testing</title>
		<link>http://pharmaexecnews.com/biotechnology/merck-kgaas-pancreatic-cancer-vaccine-ready-testing/</link>
		<comments>http://pharmaexecnews.com/biotechnology/merck-kgaas-pancreatic-cancer-vaccine-ready-testing/#comments</comments>
		<pubDate>Tue, 20 Jul 2010 08:00:11 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[Companies]]></category>
		<category><![CDATA[Deals and Mergers]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Drug Discovery]]></category>
		<category><![CDATA[Drug Trials]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Financial]]></category>
		<category><![CDATA[General News]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[Industry News Alerts]]></category>
		<category><![CDATA[International News]]></category>
		<category><![CDATA[Market News]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[Medical]]></category>
		<category><![CDATA[Medical Patents]]></category>
		<category><![CDATA[Medical Research]]></category>
		<category><![CDATA[New Drugs]]></category>
		<category><![CDATA[Oncology]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[Regulatory]]></category>
		<category><![CDATA[Research Reports]]></category>
		<category><![CDATA[Vaccines]]></category>
		<category><![CDATA[bioengineering]]></category>
		<category><![CDATA[Bioinformatics Market Potential]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[Breast cancer]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[cancer therapies]]></category>
		<category><![CDATA[lymphoma]]></category>
		<category><![CDATA[molecular biology]]></category>
		<category><![CDATA[pharmaceutical companies]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[Pharmacogenomics]]></category>
		<category><![CDATA[Prostate Cancer]]></category>
		<category><![CDATA[Strategic Alliances in World Pharma and Biotech Markets]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>
		<category><![CDATA[Understanding the Global Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=10519</guid>
		<description><![CDATA[In the quest for a cancer vaccine, Merck KGaA is again stepping into the ring. Vaximm Holding AG, the company&#8217;s joint venture with a Switzerland&#8217;s BB Biotech Ventures III, will start testing a therapeutic cancer vaccine in patients next year. The vaccine, VXM01, harnesses the body&#8217;s immune system to fight cancer by using T-cells to close off [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/merck-kgaas-pancreatic-cancer-vaccine-ready-testing/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Clinical Trial Participation Alone May Not Be Associated With Improved Outcomes for Childhood Cancer Patients</title>
		<link>http://pharmaexecnews.com/biotechnology/clinical-trial-participation-improved-outcomes-childhood-cancer-patients/</link>
		<comments>http://pharmaexecnews.com/biotechnology/clinical-trial-participation-improved-outcomes-childhood-cancer-patients/#comments</comments>
		<pubDate>Thu, 11 Mar 2010 08:00:36 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Drug Discovery]]></category>
		<category><![CDATA[Drug Trials]]></category>
		<category><![CDATA[Financial]]></category>
		<category><![CDATA[General News]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[Market News]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[Medical]]></category>
		<category><![CDATA[Medical Research]]></category>
		<category><![CDATA[Oncology]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[Research Reports]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[cancer therapies]]></category>
		<category><![CDATA[lymph]]></category>
		<category><![CDATA[lymphoma]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[Pharmacogenomics]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>
		<category><![CDATA[Understanding the Global Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=10093</guid>
		<description><![CDATA[Children with the most common childhood cancer did not experience improved outcomes from participating in a clinical trial between 1997 and 2005.

Carl Koschmann, M.D., and colleagues at the University of Washington and Seattle Children&#8217;s Hospital studied 322 patients with newly diagnosed acute lymphoblastic leukemia (a cancer involving the white blood cells), approximately half of whom [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/clinical-trial-participation-improved-outcomes-childhood-cancer-patients/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Sound of Melanoma: Ultrasound Can Help Doctors Find Cancer More Accurately</title>
		<link>http://pharmaexecnews.com/pharmaceuticals/markets/sound-melanoma-ultrasound-doctors-find-cancer-accurately/</link>
		<comments>http://pharmaexecnews.com/pharmaceuticals/markets/sound-melanoma-ultrasound-doctors-find-cancer-accurately/#comments</comments>
		<pubDate>Thu, 25 Feb 2010 08:00:12 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Devices and Technology]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Financial]]></category>
		<category><![CDATA[General News]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[Industry News Alerts]]></category>
		<category><![CDATA[International News]]></category>
		<category><![CDATA[Market News]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[Medical]]></category>
		<category><![CDATA[Medical Procedures]]></category>
		<category><![CDATA[Medical Research]]></category>
		<category><![CDATA[Oncology]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[Research Reports]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[cancer therapies]]></category>
		<category><![CDATA[lymph]]></category>
		<category><![CDATA[lymphoma]]></category>
		<category><![CDATA[molecular biology]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[Prostate Cancer]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>
		<category><![CDATA[Understanding the Global Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=10041</guid>
		<description><![CDATA[Knowing the stage of a patient&#8217;s melanoma is important when choosing the best course of treatment. When the cancer has progressed to the lymph nodes, a more aggressive treatment is needed. Examining an entire lymph node for cancer takes much effort and time. Now, a new technique might help make the process more efficient.

University of [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/pharmaceuticals/markets/sound-melanoma-ultrasound-doctors-find-cancer-accurately/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Physicists Kill Cancer with ‘Nanobubbles’</title>
		<link>http://pharmaexecnews.com/biotechnology/physicists-kill-cancer-nanobubbles/</link>
		<comments>http://pharmaexecnews.com/biotechnology/physicists-kill-cancer-nanobubbles/#comments</comments>
		<pubDate>Fri, 19 Feb 2010 08:00:33 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Financial]]></category>
		<category><![CDATA[Industry News Alerts]]></category>
		<category><![CDATA[Nanotechnology]]></category>
		<category><![CDATA[Research Reports]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[bioengineering]]></category>
		<category><![CDATA[Bioinformatics Market Potential]]></category>
		<category><![CDATA[biomolecules]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[cancer therapies]]></category>
		<category><![CDATA[lymphoma]]></category>
		<category><![CDATA[micro technology]]></category>
		<category><![CDATA[nano]]></category>
		<category><![CDATA[nanobiotechnology]]></category>
		<category><![CDATA[nanotechnology]]></category>
		<category><![CDATA[Nanotechnology - Revolutionizing R&D to Develop Smarter Therapeutics and Diagnostics]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=10010</guid>
		<description><![CDATA[Using lasers and nanoparticles, scientists at Rice University have discovered a new technique for singling out individual diseased cells and destroying them with tiny explosions. The scientists used lasers to make &#8220;nanobubbles&#8221; by zapping gold nanoparticles inside cells. In tests on cancer cells, they found they could tune the lasers to create either small, bright [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/physicists-kill-cancer-nanobubbles/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Hormone Research has Implications on Women’s Health</title>
		<link>http://pharmaexecnews.com/medical/healthcare-medical/hormone-research-implications-womens-health/</link>
		<comments>http://pharmaexecnews.com/medical/healthcare-medical/hormone-research-implications-womens-health/#comments</comments>
		<pubDate>Mon, 07 Sep 2009 09:00:15 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Women's Health]]></category>
		<category><![CDATA[Breast cancer]]></category>
		<category><![CDATA[depression]]></category>
		<category><![CDATA[lymphoma]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=1391</guid>
		<description><![CDATA[New research, which poses some serious implications on women’s health, is seeking to explain why women develop breast cancer and how they may prevent breast cancer and keep it from recurring. The findings from this new study show that hormonal balance is the best determiner of whether or not a malignant growth in a woman’s [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/medical/healthcare-medical/hormone-research-implications-womens-health/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Symptoms of Lymphoma</title>
		<link>http://pharmaexecnews.com/biotechnology/biomedical/symptoms-lymphoma/</link>
		<comments>http://pharmaexecnews.com/biotechnology/biomedical/symptoms-lymphoma/#comments</comments>
		<pubDate>Fri, 22 May 2009 06:45:43 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Oncology]]></category>
		<category><![CDATA[Cancer - Non-Hodgkin Lymphoma]]></category>
		<category><![CDATA[lymph]]></category>
		<category><![CDATA[lymphoma]]></category>
		<category><![CDATA[non-hodgkin]]></category>
		<category><![CDATA[symptoms of lymphoma]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=504</guid>
		<description><![CDATA[As recently as 1950, lymphoma was almost inevitably fatal but these days up to 90 per cent of those newly diagnosed with Hodgkin&#8217;s lymphoma can expect to be cured. Non-Hodgkin&#8217;s is less easily treated, with an overall cure rate of about 60 per cent.

There may be no symptoms until the lymphoma has spread. Lymphoma can [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/biomedical/symptoms-lymphoma/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pathology of the Epstein-Barr Virus</title>
		<link>http://pharmaexecnews.com/biotechnology/biomedical/pathology-epsteinbarr-virus/</link>
		<comments>http://pharmaexecnews.com/biotechnology/biomedical/pathology-epsteinbarr-virus/#comments</comments>
		<pubDate>Sat, 18 Apr 2009 17:19:45 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Cancer - Non-Hodgkin Lymphoma]]></category>
		<category><![CDATA[Ebstein Barr Virus]]></category>
		<category><![CDATA[epstein-barr]]></category>
		<category><![CDATA[herpes]]></category>
		<category><![CDATA[lymphoma]]></category>
		<category><![CDATA[mono]]></category>
		<category><![CDATA[non-hodgkin]]></category>
		<category><![CDATA[the]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=457</guid>
		<description><![CDATA[The Epstein-Barr Virus (EBV), also called Human herpes virus 4 (HHV-4), is a virus of the herpes family (which includes Herpes simplex virus), and is one of the most common viruses in humans. Most people become infected with EBV, which is often asymptomatic but commonly causes infectious mononucleosis.

EBV is named after Michael Epstein and Yvonne [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/biomedical/pathology-epsteinbarr-virus/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Failure of Treatment in Lymphoma</title>
		<link>http://pharmaexecnews.com/biotechnology/biomedical/failure-treatment-lymphoma/</link>
		<comments>http://pharmaexecnews.com/biotechnology/biomedical/failure-treatment-lymphoma/#comments</comments>
		<pubDate>Thu, 05 Mar 2009 18:16:15 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Oncology]]></category>
		<category><![CDATA[Blood and Lymphatic System - Dyslipidemia]]></category>
		<category><![CDATA[Hodgkin]]></category>
		<category><![CDATA[lymph]]></category>
		<category><![CDATA[lymphoma]]></category>
		<category><![CDATA[stages of lymphatic cancer]]></category>
		<category><![CDATA[treatment of lymphatic cancer]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=396</guid>
		<description><![CDATA[Lymphoma is a group of neoplasms that derive from immune cells residing in the lymph system. The nosology used to differentiate these neoplasms has evolved hand-in-hand with the evolution of the understanding of the immune system and its malignancies. The key distinctions between types of lymphoma are based on cell type and rate of growth. [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/biomedical/failure-treatment-lymphoma/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

